Arbutus Biopharma Corporation (ABUS)
Q2 2020 Earnings Conference Call
August 7, 2020 08:45 a.m. ET
Company Representatives
Bill Collier - President, Chief Executive Officer
Mike Sofia - Chief Scientific Officer
Gaston Picchio - Chief Development Officer
Dave Hastings - Chief Financial Officer
Pam Murphy - Investor Relations
Conference Call Participants
Mayank Mamtani - B. Riley
Roy Buchanan - JMP Securities
Presentation
Operator
Ladies and gentlemen, thank you for standing by and welcome to the Arbutus Biopharma Corporate 2020 Second Quarter Financial Results and Corporate Update Conference Call. At this time all participants are in a